Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Only one chair will fit David Gonski as he joins Sydney Airports board

2018-07-12 theage.com.au
When someone as high profile as David Gonski joins a board like Sydney Airports you can bet your house that he has already been lined up for the big chair.
MQBKY SYD MOC MCQEF MQG SYDDF

0
Only one chair will fit David Gonski as he joins Sydney Airports board

2018-07-12 smh.com.au
When someone as high profile as David Gonski joins a board like Sydney Airports you can bet your house that he has already been lined up for the big chair.
MQBKY SYD MOC MCQEF MQG SYDDF

0
Mortgage Choice to take profit hit to ward off franchisee revolt

2018-07-12 abc.net.au
Mortgage Choice is overhauling its payment structure, after aggrieved franchisees spoke out against the publicly listed mortgage broker.
MOC

0
Mortgage Choice shares slump as it overhauls franchisee pay model

2018-07-12 theage.com.au
Mortgage Choice is vowing to lift the share of revenue it pays to franchisee mortgage brokers, in an overhaul of its remuneration model that will inflict a $30 million one-off hit on its full-year profit.
MOC

0
Mortgage Choice shares slump as it overhauls franchisee pay model

2018-07-12 smh.com.au
Mortgage Choice is vowing to lift the share of revenue it pays to franchisee mortgage brokers, in an overhaul of its remuneration model that will inflict a $30 million one-off hit on its full-year profit.
MOC

1
How to finance the perfect renovation

2018-07-01 ntnews.com.au
AUSTRALIANS love renovating, with a study revealing 56 per cent have completed works on their home or investment property since buying and another 20 per cent plan to do so in the next year. But experts warn any added value can be lost by making the wrong finance choices.
HRB MOC

0
CBA amputates toxic wealth management arm before poison spreads

2018-06-25 theage.com.au
Five years after Commonwealth Bank whistleblower Jeff Morris burst onto the scene with explosive allegations of rampant misconduct and conflicts in its financial planning arm, the bank has put up the white flag on vertical integration.
MOC

0
CBA amputates toxic wealth management arm before poison spreads

2018-06-25 smh.com.au
Five years after Commonwealth Bank whistleblower Jeff Morris burst onto the scene with explosive allegations of rampant misconduct and conflicts in its financial planning arm, the bank has put up the white flag on vertical integration.
MOC

0
How to be your own mortgage broker

2018-06-12 smh.com.au
Getting a home and loan is always a Geronimo moment. But never is the leap more nerve-racking than today.
MOC

0
'Inherently unfair': the human misery of franchising

2018-06-08 theage.com.au
Franchising by its very nature is inherently unfair, says former Brumby’s franchising chain founder Michael Sherlock.
RFGPF MOC RFG

0
'Inherently unfair': the human misery of franchising

2018-06-08 smh.com.au
Franchising by its very nature is inherently unfair, says former Brumby’s franchising chain founder Michael Sherlock.
RFGPF MOC RFG

0
Metcash facing $352 million hit

2018-06-06 ntnews.com.au
THE Australian share market looks set to open half a per cent higher after comfortable rises on key overseas indexes and another record higher for the Nasdaq. At 0700 AEST on Thursday, the share price futures index was up 30 points, or 0.5 per cent, at 6054.
MOC

4
House rules: Mortgage Choice boss turns the camera on herself

2018-06-06 theage.com.au
Mortgage Choice investors should have smelt a rat two months ago when its CEO, former NAB executive John Flavell, resigned with zero notice and was replaced by his veteran CFO, Susan Mitchell, who had already resigned to take a number-crunching role elsewhere.
DB MOC

4
House rules: Mortgage Choice boss turns the camera on herself

2018-06-06 smh.com.au
Mortgage Choice investors should have smelt a rat two months ago when its CEO, former NAB executive John Flavell, resigned with zero notice and was replaced by his veteran CFO, Susan Mitchell, who had already resigned to take a number-crunching role elsewhere.
DB MOC

0
The day journalistic royalty visited the SMH newsroom

2018-06-06 smh.com.au
It’s not every day we have journalistic royalty visiting the Herald’s newsroom. On Monday, I hosted a lunchtime talk-fest for reporters with Boston Globe investigative journalist Walter Robinson.
MOC

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:MOC / MORTGAGE CHOICE LIMITED on message board site Silicon Investor.

Left Wing Democratic Porch Support the French! Viva Democracy!
ILLEGAL IMMIGRATION THE FIGHT TO KEEP OUR DEMOCRACY The collaspe of European democracy
BP: BP Amoco p.l.c. Fair and Balanced-u0027Duties Of a Democracyu0027
DEMOCRATIC NIGHTMARE - 2008 CANDIDATES Those Damned Democratu0027s
BILL CLINTON - DEMOCRAT, LIAR AND DECEIVER What does it mean to be a Democrat?